Perimenopause
The term "perimenopause", which literally means "around the menopause", refers to the menopause transition years, a span of time both before and after the date of the final episode of flow. According to the North American Menopause Society, this transition can last for four to eight years. During perimenopause, estrogen levels average about 20-30% higher than during premenopause, often with wide fluctuations. These fluctuations cause many of the physical changes during perimenopause as well as menopause. During this period, fertility diminishes, but is not considered to reach zero until the official date of menopause. The actual duration and severity of perimenopause effects for any individual woman currently cannot be predicted in advance. Even though the process, or the course, of perimenopause or menopause can be difficult to predict, the age of onset is somewhat predictable: women will often, but not always, start these transitions (perimenopause and menopause) about the same time as their mother did.
Postmenopause
The term "postmenopausal" describes women who have not experienced any menstrual flow for a minimum of 12 months, assuming that they do still have a uterus, and are not pregnant or lactating. In women without a uterus, menopause or postmenopause can be identified by a blood test showing a very high FSH level. Thus postmenopause is all of the time in a woman's life that take place after her last period, or more accurately, all of the time that follows the point when her ovaries become inactive. At this point a woman is considered infertile; however, the possibility of becoming pregnant has usually been very low (but not quite zero) for a number of years before this point is reached.
Menopause is usually a natural change. This transition from a potentially reproductive to a non-reproductive state is the result of changes in female hormonal production by the ovaries. Normally not sudden or abrupt, tends to occur over a period of years, and is a consequence of biological aging. For some women, the accompanying signs and effects that can occur during the menopause transition years can significantly disrupt their daily activities and sense of well-being. Specific treatment is not usually needed. Some symptoms, however, may be improved with treatment.
In those who have had surgery to remove the uterus but still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when hormone levels fall. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age. Other causes include surgery that removes both ovaries, or some types of chemotherapy. While typically not needed, a diagnosis of menopause can be confirmed by measuring hormone levels in either the blood or urine. Menopause is the opposite of menarche, the time at which a girl's periods start.
Menopause can result from:
Age
The typical age of menopause is between 40 and 61 and the average age for last period is 51 years. Menopause that occurs before the age of 40, whether natural or induced, is known as "premature" menopause.
Premature ovarian failure
In rare cases, a woman's ovaries stop working at a very early age, ranging anywhere from the age of puberty to age 40, and this is known as premature ovarian failure (POF). The diagnosis is made when women younger than 40 years, have four or more months of amenorrhea and two serum FSH levels taken one month apart in the menopausal range. Previously the term premature menopause had been used as synonym to POF but found to be incorrect; as about 50% of women have intermittent ovarian function and may ovulate and conceive after this diagnosis.
Chemotherapy-induced premature menopause
Chemotherapy-induced premature ovarian failure is reversible for the infertility of women. Damaged ovarian function can be rescued after stem cell transplantation. Nevertheless, the mechanism behind this still remains unclear. Although these stem cells may potentially differentiate into oocytes or granulosa cells, studies have proved they could not develop into fully functional follicles in vivo. Both the proliferation and apoptosis of granulosa cells are critical in the development of follicles. Greater numbers of studies have revealed stem cells transplanted into the damaged ovary are more inclined to differentiate into granulosa celllike cells to replenish the lost granulosa cells. Additionally, factors produced by stem cells could inhibit stromal cell apoptosis, thereby playing a part in rescuing damaged ovarian function.
Surgical menopause
Menopause can be surgically induced by bilateral oophorectomy (removal of ovaries), which is often, but not always, done in conjunction with removal of the Fallopian tubes (salpingooophorectomy) and uterus (hysterectomy). Cessation of menses as a result of removal of the ovaries is called "surgical menopause". The sudden and complete drop in hormone levels usually produces extreme withdrawal symptoms such as hot flashes, etc.
Associated disease
Reduced estrogen levels lead to an increased risk of osteoporosis, and increased risk for colon and ovarian cancer.
Complications
While menopause is often thought to be linked to an increase in heart disease, this primarily occurs due to increasing age and does not have a direct relationship with menopause. A possible but contentious increased risk of atherosclerosis.
Risk factors
Factors related to earlier age at menopause include childhood undernutrition, low menstrual cycles, never having given birth, low socioeconomic status, low education level, rural living, and lifestyle factors such as smoking or alcohol consumption.
Factors that lower the age of physiologic menopause include: hysterectomy Fragile X carrier autoimmune disorders living at high altitude history of certain chemotherapy medications and/or radiation treatment  Impact on fertility Chances of conception after menopause are very small but possible. In some cases, early diagnosis by genetic investigation may instead lead to advice for early conception or oocyte harvesting and preservation. Hormone defect may be substituted by estrogen/progestin preparations. Moreover, sexual hormone defects represent an important risk factor for frequent and severe neurological, metabolic or cardiovascular disorders such as Alzheimer's disease, hypercholesterolemia or ischemic diseases. The only solution presently available for the fertility defect in women with absent follicular reserve is represented by ovum donation. Gestation after menopause is with complications. The health of the mother and of the baby is at risk.
 Prevention
Physical activity may be an effective way of preventing or attenuating menopause-related symptoms, and it has been shown to improve quality of life in menopausal women. Nutrition plays an important role in the prevention and management of changes in body composition, but the role of nutrition in treating symptoms such as hot flashes is unclear.
 Symptoms
Vasomotor symptoms such as; hot flashes and night sweats; somatic symptoms such as vaginal dryness and dyspareunia; psychological symptoms such as anxiety, nervousness, lack of concentration, overreacting to mild problems, irritability, and poor memory, are all symptoms of menopause. However, the severity and influence of these symptoms of menopause in different women and populations are varied. In some women, these symptoms are so severe that they affect their social and individual lives. Decreased estrogen secretion, metabolic changes, general health and psychosocial factors result in menopausal symptoms. The frequency of symptoms can vary based on epidemiological characteristics of the population and the assessment tools used.
 Therapies

 Self therapy
Alternative medicine
In the area of complementary and alternative therapies, acupuncture and acupressure treatments are promising. Numerous studies indicate positive effects, especially on hot flashes but also others showing no positive effects of acupuncture regarding menopause.
With respect to hot flashes, avoiding smoking, caffeine, and alcohol is often recommended.
 Conventional medicine Pharmacotherapy
There are a number of treatments to relieve the symptoms of menopause:
Hormone replacement therapy (HRT) Hormone replacement therapy (HRT) in menopause is medical treatment in surgically menopausal, perimenopausal and postmenopausal women. Its goal is to mitigate discomfort caused by diminished circulating estrogen and progesterone hormones in menopause. Combination HRT is often recommended as it decreases the amount of endometrial hyperplasia and cancer associated with unopposed estrogen therapy. The main hormones involved are estrogen, progesterone and progestin. Some recent therapies include the use of androgens as well.
Tibolon
Tibolone is an alternative to estrogen replacement therapy for the treatment of climacteric complaints and postmenopausal bone loss while not having harmful effects on the endometrium and the breast.
Selective estrogen receptor modulators (SERMs)
SERMs are used for various estrogen-related diseases. Including treatment of ovulatory dysfunction in the management of infertility, treatment and prevention of postmenopausal osteoporosis, treatment and reduction in risk of breast cancer and treatment of dyspareunia due to menopause. SERM is also used in combination with conjugated estrogens indicated for the treatment of estrogen deficiency symptoms, and vasomotor symptoms associated with menopause.
Surgical therapy
Operation is not menopause treatment, but conditions requiring surgery become more common during menopause. Menopause surgery may be necessary to relieve symptoms of menopause (e.g vaginal bleeding).
 Assisted reproduction
Motherhood after the age of menopause, facilitated by assisted reproductive technologies (ARTs), has raised much controversy in recent decades. To date, pregnancy in postmenopausal women has required the use of donated oocytes by using oocytes from a younger donor (even when the prospective mother still has her own).
Subsequent to recent developments, oocytes can now be preserved much more effectively than before, through vitrification. However, oocyte preservation will be useful only if a woman knows of its existence, while she is still young enough to have healthy eggs, and has access to it. For those who are already heading toward agerelated subfertility or menopause, the possibility of vitrification offers little hope.
